Literature DB >> 9824164

BRCA2 associates with acetyltransferase activity when bound to P/CAF.

F Fuks1, J Milner, T Kouzarides.   

Abstract

Predisposition to hereditary breast cancer has been attributed in part to inherited mutations in the BRCA2 gene. The large protein it encodes is still poorly characterized with respect to functions. We have previously shown that BRCA2 has transcriptional activation potential conferred by its amino-terminal third exon. Here, we show that BRCA2 interacts with a transcriptional co-activator protein, P/CAF, which possesses histone acetyltransferase activity. The interaction with P/CAF is demonstrated in vitro as well as in vivo and is shown to be mediated by residues 290-453 of BRCA2. Consistent with the binding to an acetyltransferase, BRCA2 is shown to associate with acetyltransferase activity in nuclear extracts. Contrary to a recent report, we find no evidence in support of an intrinsic HAT activity in BRCA2 amino-terminus. Our results further substantiate the notion that BRCA2 has transcriptional activation function and suggest that one mechanism by which BRCA2 regulates transcription may be through the recruitment of histone-modifying activity of the P/CAF co-activator.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824164     DOI: 10.1038/sj.onc.1202475

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

Review 1.  Acetylation: a regulatory modification to rival phosphorylation?

Authors:  T Kouzarides
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

2.  Chromatin remodeling and activation of chromosomal DNA replication by an acidic transcriptional activation domain from BRCA1.

Authors:  Y F Hu; Z L Hao; R Li
Journal:  Genes Dev       Date:  1999-03-15       Impact factor: 11.361

3.  IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors.

Authors:  Silvia Maifrede; Kayla Martin; Paulina Podszywalow-Bartnicka; Katherine Sullivan-Reed; Samantha K Langer; Reza Nejati; Yashodhara Dasgupta; Michael Hulse; Daniel Gritsyuk; Margaret Nieborowska-Skorska; Lena N Lupey-Green; Huaqing Zhao; Katarzyna Piwocka; Mariusz A Wasik; Italo Tempera; Tomasz Skorski
Journal:  Mol Cancer Res       Date:  2017-06-20       Impact factor: 5.852

4.  BRCA1 and BRCA2 in breast cancer predisposition and recombination control.

Authors:  Ralph Scully; Anyong Xie
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

5.  Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma.

Authors:  Jie Jiao; Tongzhang Zheng; Qing Lan; Yingtai Chen; Qian Deng; Xiaofeng Bi; Christopher Kim; Theodore Holford; Brian Leaderer; Peter Boyle; Yue Ba; Zhaolin Xia; Stephen J Chanock; Nathaniel Rothman; Yawei Zhang
Journal:  Eur J Cancer Prev       Date:  2012-11       Impact factor: 2.497

Review 6.  BRCA2 and pancreatic cancer.

Authors:  Ali Naderi; Fergus J Couch
Journal:  Int J Gastrointest Cancer       Date:  2002

7.  The overexpression of MYST4 in human solid tumors is associated with increased aggressiveness and decreased overall survival.

Authors:  Chao-Lien Liu; Jim Jinn-Chyuan Sheu; Hsuan-Ping Lin; Yung-Ming Jeng; Cherry Yin-Yi Chang; Chih-Mei Chen; Jack Cheng; Tsui-Lien Mao
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

8.  A new assay for functional screening of BRCA2 linker region mutations identifies variants that alter chemoresistance to cisplatin.

Authors:  Curtis R Warren; Zohra Ali-Khan Catts; Mary C Farach-Carson
Journal:  Exp Cell Res       Date:  2011-06-29       Impact factor: 3.905

9.  Novel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer patients and a family with BRCA1 mutations.

Authors:  Sumadee DE Silva; Kamani H Tennekoon; Eric H Karunanayake; Wasanthi DE Silva; Indrani Amarasinghe; Preethika Angunawela
Journal:  Exp Ther Med       Date:  2011-08-17       Impact factor: 2.447

10.  BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription.

Authors:  Sook Shin; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.